Case Reports in Medicine

Volume 2014 (2014), Article ID 564926, 5 pages

http://dx.doi.org/10.1155/2014/564926

Case Report

Clinical Case of Immune Dysregulation, Polyendocrinopaty, Enteropathy, X-Linked (IPEX) Syndrome with Severe Immune Deficiency and Late Onset of Endocrinopathy and Enteropathy

R. Savova,¹ M. Arshinkova,¹ J. Houghton,² M. Konstantinova,¹ M. Gaydarova,¹ E. Georgieva,¹ G. Popova,¹ V. Genova,¹ N. Tomova,¹ A. Anadoliiska,¹ and K. Koprivarova¹

¹University Pediatric Hospital, Sofia, Bulgaria

²Medical School, University of Exeter, UK

Received 6 November 2013; Revised 27 April 2014; Accepted 27 April 2014; Published 1 June 2014

Academic Editor: Nima Rezaei

Copyright © 2014 R. Savova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. To describe the clinical characteristics of IPEX syndrome in a child with FOXP3 mutation. Clinical Case. A boy aged 2.3 years was born from first normal pregnancy with a weight of 3420 gr. Family History. Two brothers of the mother died before the age of 3 years with severe infections, diarrhea, erythroderma, and elevated immunoglobulins class E (IgEs). Since first month of life, our patient suffered from septicemia, pneumonias, pyelonephritis, and meningitis, accompanied with eczematous dermatitis and IgEs up to 4000 IU/L (normal <10). At the age of 1.6 years, he developed type 1 diabetes mellitus (T1DM). He was underweighted (−3.42 SDS) and had some phenotypic features like coarse face, muscle hypotonia, joint hyperextensibility, eczematous dermatitis, and subcutaneous cold abscesses. Autoimmune thyroiditis and celiac disease were excluded. After diabetes, intermittent watery diarrhea appeared with progression to severe intractable form. Finally, aggravating symptoms of nephritis, cachexia, and respiratory insufficiency were the cause for his death at the age of 2 years and 3 months. The DNA analysis at the University of Exeter Medical School established mutation at exon 10 of FOXP3 gene c.1010G >A, p. (Arg337Gln), which confirmed IPEX syndrome. The same mutation in heterozygotic state was found in the mother. A prenatal diagnosis of her second pregnancy ensured a daughter carrier of the mutation.

1. Introduction

Type 1 diabetes mellitus (T1DM) is an autoimmune disease which incidence rises worldwide being triggered by unknown yet environmental factors. The etiology is considered to be multifactorial. The major histocompatibility complex (MHC) on chromosome 6p21.3 is the main susceptibility locus for many autoimmune diseases [1] and for type 1 DM as well [2]. The second most important is insulin gene (INS) on chromosome 11p15 [2]. Genome-wide linkage analysis for T1DM-susceptibility loci supports an interaction between HLA and more than 40 non-HLA loci and evaluated a series of non-HLA genes responsible for immune regulation: CTLA-4 on 2q33.2 and 17p13.1, PTPN22 on 1p13.2, interleukin- (IL-) 2 receptor α chain (IL2RA) on 10p15, IFIH1 on 2q24.2, IL10, IL19, and IL20 on 1q32.1, CD69 on 12p13.31, IL27 on 16p11.2, and PTPN2 on 18p11.21 [3–5]. T1DM is often present in autoimmune polyendocrine syndrome type 1 (APS1) and type 2 (APS2) and IPEX syndrome, reaching 20% in APS1, 50% in APS2, and 60% in IPEX [6]. These syndromes are caused by immunologically mediated destructive process conducted by autoreactive T cells, which damage multiple endocrine organs and nonendocrine tissues due to compromised central (APS1) or peripheral (APS2) immune tolerance. In patients with primary immune deficiency disorders (PIDDs), a breakdown of self-tolerance mechanisms often exists with high incidence of autoimmunity. FOXP3 functions as a master of transcription for the development of regulatory T cells (T-reg) both in human and in mice. In the patients with IPEX syndrome, the lack of the forkhead box protein 3 in lymphoid tissues (thymus, spleen, and lymph nodes), encoded by FOXP3 gene at Xp11.23-Xq13.3, leads to impaired development and suppressed function of CD4+CD25+ -reg. It causes dysfunction of the effector T cells (T-eff) and predisposes to multiple autoimmune diseases as well. The protein, encoded by FOXP3, has 4 functional domains in its molecular structure: (1) N-terminal proline-rich repressor domain; (2) zinc-finger domain; (3) leucine-zipper domain; (4) and DNA-binding forkhead/winged helix domain (FKH) [7]. Mutations that affect any of these key functional domains may alter or abrogate the ability of the transcription factor to regulate gene expression in T-reg. Recent studies showed that mature naïve B cells from IPEX patients often expressed autoreactive antibodies, suggesting an important role for T-reg in maintaining peripheral B cell tolerance [8] and B cell anergy [9]. IPEX syndrome is an X-linked genetic disorder in which T1DM is a common feature and can be seen as early as in the 1st month of life. In the cohort of persistent genetically inherited neonatal diabetes, IPEX-related diabetes is unique because of its autoimmune nature. It was found in 4% of neonatal permanent diabetes among males [10]. Other symptoms due to profound immune dysregulation that can be seen in males with IPEX syndrome include enteropathy (100%), dermatitis (65%), failure to thrive (50%), thyroiditis (30%), and recurrent infections (20%). Many other autoimmune phenomena like nephritis, pneumonitis, hepatitis, vasculitis, arthritis, myositis, alopecia, and autoimmune cytopenias can be presented [11]. Severe watery diarrhea and life-threatening infections shorten the lifespan of these patients and they usually die in the first 1-2 years of life.

The aim of our paper is to present a boy with IPEX syndrome and to highlight the main clinical characteristics and outcome of this severe disorder. The boy was aged 2 years and 3 months at the time of the last hospitalization. Family history is as follows: healthy parents, but two brothers of the mother died at age of 7 months and 3 years with severe infections, chronic diarrhea, and skin eruptions reported as eczematous dermatitis/erythroderma. In one of them, highly elevated IgEs were measured and Job syndrome was suspected. The boy presented here was born after first normal pregnancy by Cesarean section with a weight of 3420 g and length of 51 cm. Oxygen therapy was provided 10 days after delivery. At the age of 1 month, he was hospitalized for pneumonia and septicemia due to Streptococcus pneumoniae. Skin eruptions assessed as erythroderma were present. Humoral immunity was evaluated and elevated IgEs 855 IU/mL were found. Positive specific IgEs toward cow’s milk proteins were established and feeding with dietary hypoallergic formula was introduced. In early infancy, the child suffered from multiple severe bacterial infections, pruritic eczematous dermatitis, elevated IgEs, and eosinophilia. Hypotrophy, subcutaneous cold abscesses, and enlarged peripheral lymph nodes appeared over time together with other phenotypic features resembling Job syndrome like coarse face and joint hyperextensibility. At the age of 1 year and 6 months, autoimmune diabetes mellitus was diagnosed. After diabetes, watery diarrhea appeared, being intermittent initially, but persisting during the second year of age and leading to severe malnutrition (Table 1).

Table 1: Disease history with main symptoms, somatic features, and laboratory data.

Age
Weight/height SDS
Main diagnosis and symptoms. Treatment
Somatic features
Laboratory features

1 month
N/A
Septicemia, pneumonia
Erythroderma
IgE 855 IU/mL (<10)

3–5 months
N/A
Pneumonias

Urinary tract infections

Intermittent dyspepsia

Meningitis
Hypotrophy

Enlarged peripheral lymph nodes Pruritic eczematous dermatitis
N/A

6 months
Weight 4590 g (−3.67 SDS)

Height 60 cm (−2.6 SDS)
Bronchiolitis

Complex treatment with respiratory therapy, antibiotics, topical emollients/steroids, antihistamines, and dietary feeding with protein hydrolyzed lactose free formula
Hypotrophy

Enlarged peripheral lymph nodes

Pruritic eczematous dermatitis

Muscle hypotonia

Left kidney malrotation

Hydronephrosis and mild vesicoureteral reflux
IgG 9.11 g/L (1.39–9.34) IgM 1.02 g/L (0.2–1.2)

IgA 0.38 g/L (0.04–0.78)

IgE > 4000 IU/mL (<10)

Eosinophilia 13%

Normal T and B cell subset quantification

Mild iron deficiency

Hemoglobin 115 g/L

1.6 years
7400 g

(−3.42 SDS)
Diabetes mellitus

Right thigh phlegmon

Transient watery diarrhea with weight loss up to 6800 g

Insulin dose of 1.3 U/kg b.w.

Surgical incision and antibiotics

Protein hydrolyzed lactose free formula and gluten-free diet
Coarse face with prominent forehead, broad nasal bridge, bulbous nose, and macroglossia

Joint hyperextensibility Subcutaneous cold abscesses on the neck and face

Eczematous dermatitis

Napkin’s dermatitis Balanoposthitis
Blood sugar 27 mmol/L

No ketones

Anti-GAD65 antibodies 32 ng/mL (normal <32)

Anti-insulin antibodies 60.1 IU/mL (<10)

Basal C-peptide 158.7 pmol/L (198–960)

Tissue transglutaminase IgA antibodies 5.2 U/mL (<7.0)

TSH 1.34 mIU/L (0.4–4.2)

fT4 11.2 pmol/L (9.8–18.9)

1.9 years
9300 g

(−2.80 SDS)
Intermittent watery diarrhea

Insulin dose 0.75 U/kg b.w.

Lactose/gluten-free diet
Mentioned above
HbA1c 7.65% (4–6) (COBAS INTEGRA/Roche diagnostic system)

2.1–2.3 years
7000–11500 g
Severe watery diarrhea Hypoglycemias

Vomiting and intolerance to oral feeding

Reduced insulin dose 0.3 to 0.1 U/kg b.w

Parenteral nutrition

Antibiotics i.v.

Corticosteroids i.v.

Drainage of peritoneal transudation

Diuretics
Mentioned above + severe malnutrition

Enlarged tensed abdomen, visible abdominal wall veins, intestinal sacculations, and significant abdominal dropsy

Lung hypervolemia on X-ray examination
Proteinuria with granular and hyaline casts

Hypoproteinemia 52.8 g/L

Na 120 mmol/L

Ca 1.89 mmol/L

K 3.9 mmol/L

Metabolic nonketotic acidosis (pH 7.15)

Normal urea

Creatinine and transaminases

Uroculture negative

Varied bacterial and  Candida contamination of the stools

At the last hospitalization, the main clinical characteristics were severe malnutrition, cachexy, and fluid retention due to hypoproteinemia. A complex treatment was provided with total parenteral nutrition, drainage of peritoneal transudation, antibiotics, and diuretics. Insulin reduction to 0.3 U/kg b.w. did not lead to ketoacidosis. One week later, a new symptom was tachypnea with bilateral crepitate of the lung without initial pathologic changes on the first X-ray examination. Blood oxygen saturation fell down and oxygen supply was started. The child was highly oxygen dependent and cyanosis appeared minutes after discontinuation of the oxygen. Corticosteroid treatment with methylprednisolone i.v. at a daily dose of 3 mg/kg b.w. was the last attempt to help the child. Some minimal clinical benefit with reduced watery stools and better tolerance to oral feeding was observed, but severe respiratory insufficiency persisted and was the cause of the death. The bronchial smear for Pneumocystis carinii could not be investigated. The parents did not agree on autopsy and some specific organ damages remained obscure.

After the diagnosis of diabetes, DNA samples of the child and the parents were sent to the University of Exeter Medical School. The DNA analysis found mutation at exon 10 of FOXP3 gene c.1010G > A, p. (Arg337Gln), which confirmed IPEX syndrome. The same mutation in heterozygotic state was found in the mother. A prenatal diagnosis of her second pregnancy was performed and a daughter carrier of the mutation was born.

2. Discussion

If a patient has immune deficiency and hyper-IgE syndrome without the classical triad of watery diarrhea, dermatitis, and T1DM/autoimmune thyroiditis in the first months of life, pediatricians should consider several primary immune deficiency disorders with hyper-IgE syndrome: hyper-IgE syndrome (HIES) or Job syndrome, Wiskott-Aldrich syndrome, IPEX, Omenn syndrome, and atypical complete DiGeorge syndrome [12].

Some phenotype characteristics of our patient like coarse face, hyperextensible joints, eczematous dermatitis, and clinical history of severe recurrent infections with hyper-IgE syndrome resembled Job syndrome and this diagnosis was considered before the development of watery diarrhea and autoimmune diabetes. HIES is now recognized as a primary immunodeficiency disease characterized by recurrent skin abscesses, cold abscesses, recurrent pneumonia with pneumotocele, eczematous dermatitis, and elevated serum IgEs together with nonimmune features like coarse face, joint hyperextensibility, and skeletal/dental abnormalities. HIES was initially reported to have an autosomal dominant (AD) inheritance pattern, but cases with autosomal recessive (AR) inheritance and sporadic ones have been reported. AR HIES differs from AD HIES with lack of skeletal or dental anomalies and pnematocele development, but with susceptibility to viral infection including Molluscum contagiosum and neurological complications for unknown reasons [13]. Mutations of the signal transducer and activator of transcription 3 (STAT3) gene on 17q21.2 and deficiency of DOCK8 (dedicator of cytokinesis 8) on 9p24.3 are now known to cause a combined immunodeficiency rendering most of the affected patients susceptible to viral, fungal, and bacterial infections.

In our patient with primary immune deficiency with hyper-IgE, the diagnosis of IPEX syndrome was considered after diabetes and watery diarrhea appeared during the second year of life. The mutation found R337Q corresponded with more severe and classical clinical presentation of the disorder [10] with enteropathy, dermatitis, and autoimmune diabetes. This mutation is located at FKH domain, which spans over amino acids 337–421 in the C-terminal region of the protein. Like the N-terminal region, FKH is necessary for most aspects of FOXP3 function [7]. In typical cases, severe enteropathy and diabetes developed as early as the first month of life. In some patients, an intrauterine hypotrophy and pancreatic hypoplasia showed very early autoimmune process [10]. Hyper-IgE, eczematous dermatitis, and immune deficiency with recurrent infections and cold abscesses typical not only for Job syndrome but also for IPEX syndrome were present in our patient. We can speculate about the presence of aggravating autoimmune nephritis and pneumonitis but organ biopsy could not be performed because of the critical condition of our patient. Other genes possibly related to severe immune deficiency were not investigated. The same FOXP3 mutation was suspected in both brothers of the mother who died in early infancy with immune deficiency and hyper-IgE.

X-linked syndrome with diarrhea, polyendocrinopathy, and fatal infections in infancy was reported for the first time by Powell et al., in 1982 [14]. Later, Shigeoka et al. reported that a novel X-linked immunodeficient disease with autoimmunity and enteropathy had a locus mapped next to the Wiskott-Aldrich locus Xp11.2 [15]. Ferguson et al. performed linkage analysis on 20 members of affecter kindred mapping the locus to the pericentromeric region Xp11.23-q21.1 [16] and concluded that this was an X-linked disorder, distinct from Wiscott-Aldrich syndrome. By linkage analysis in a large pedigree, Bennet et al. mapped the locus for X-linked polyendocrinopathy, immune dysfunction, and diarrhea (IPEX) to a 17 cM interval defined by markers DXS8083 and DXS8107 at Xp11.23-q13.3 [17]. Torgerson, 2007, investigated a possible phenotype-genotype correlation in more than 100 symptomatic patients from more than 50 families. In the patients with a clinical phenotype compatible with IPEX, approximately 50% were found to have mutations in FOXP3. These include missense, splice site, and deletion mutations [18]. After adding new genetically proven cases to the cohort of IPEX syndrome over the world, considerable clinical heterogeneity was established. Some mutations of FOXP3 lead to functionally hypomorphic proteins that presented milder clinical features of the syndrome and partially suppressed T-reg [19]. Some mutations that do not abrogate the forkhead domain were found in 7-year-old boy and unrelated 24-year-old men with autoimmune enteropathy not associated with T1 DM or other endocrinopathies [20]. A minimal change nephrotic syndrome together with classical presentation of IPEX was reported by Hashimura et al. [21]. Neonatal diabetes and nephrotic syndrome were reported as the only clinical features in the surviving 15-year-old patient with mutation V408M of FOXP3 [10]. IPEX was genetically proven in 11-year-old boy with diabetes, pure red cell aplasia, membranous glomerulopathy, and posterior reversible encephalopathy syndrome after a vaccination against influenza virus [22]. These atypical clinical presentations of IPEX indicated existing possible underestimation of the real morbidity. Similar genotypes did not always result in similar phenotypes in terms of disease presentation and severity of IPEX [23]. Several epigenetic regulations of FOXP3 expression like methylation of CpG residues were reviewed by Lal and Bromberg [24]. A highly conserved CpG enriched element located at 5′ UTR of FOXP3 was identified as the T-reg specific demethylated region (TSDR) [25]. Demethylated CpG supports full expression of FOXP3. It is constantly demethylated exclusively in T-reg but not in T-eff, where it is fully methylated. Unlike fluocytometry demethylation status of TSDR could differentiate peripheral T-reg from T-eff, which are CD25 and FOXP3 positive when activated in a state of inflammation. After analyzing demethylation status of TSDR of FOXP3 within peripheral CD3+T cells of 28 IPEX-like patients (including females) without FOXP3 mutation, Barzaghi et al. [26] showed significantly reduced amount of peripheral T-reg, compared to both healthy subjects and unrelated disease controls.

Etiology of immune phenomena in other IPEX-like patients needs to be established in the future.

3. Conclusion

We present a classical case of IPEX syndrome in a boy with severe immune deficiency, hyper-IgE, and eczematous dermatitis in the first year of life and late onset endocrinopathy and intractable watery diarrhea during second year. The identification of a FOXP3 mutation in this family was important to predict prognosis for the child and risk for future offspring and enabled prenatal genetic diagnosis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

Genetic testing for neonatal diabetes was performed at the University of Exeter Medical School (UK) with funding from the Wellcome Trust to Professors Andrew Hattersley and Sian Ellard.

References

J. D. Rioux, P. Goyette, T. J. Vyse et al., “Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 44, pp. 18680–18685, 2009.

European Consortium for IDDM Genome Studies, “A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions,” The American Journal of Human Genetics, vol. 69, no. 6, pp. 1301–1313, 2001.

J. A. Todd, N. M. Walker, J. D. Cooper et al., “Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes,” Nature Genetics, vol. 39, no. 7, pp. 857–864, 2007.

J. C. Barrett, D. G. Clayton, P. Concannon et al., “Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009.

F. Moore, M. L. Colli, M. Cnop et al., “PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ- induced pancreatic β-cell apoptosis,” Diabetes, vol. 58, no. 6, pp. 1283–1291, 2009.

E. S. Husebye and M. S. Anderson, “Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis,” Immunity, vol. 32, no. 4, pp. 479–487, 2010.

E. D'Hennezel, K. B. Dhuban, T. Torgerson, and C. Piccirillo, “The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome,” Journal of Medical Genetics, vol. 49, no. 5, pp. 291–302, 2012.

T. Kinnunen, N. Chamberlain, H. Morbach et al., “Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells,” Blood, vol. 121, no. 9, pp. 1595–1603, 2013.

S. M. Leonardo, J. A. Josephson, N. L. Hartog, and S. B. Gauld, “Altered B cell development and anergy in the absence of Foxp3,” Journal of Immunology, vol. 185, no. 4, pp. 2147–2156, 2010.

O. Rubio-Cabezas, J. A. L. Minton, R. Caswell et al., “Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes,” Diabetes Care, vol. 32, no. 1, pp. 111–116, 2009.

D. Moraes-Vasconcelos, B. T. Costa-Carvalho, T. R. Torgerson, and H. D. Ochs, “Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED,” Journal of Clinical Immunology, vol. 28, supplement 1, pp. S11–S19, 2008.

E. Ozcan, L. D. Notarangelo, and R. S. Geha, “Primary immune deficiencies with aberrant IgE production,” Journal of Allergy and Clinical Immunology, vol. 122, no. 6, pp. 1054–1064, 2008.

H. Jyonouchi and R. W. Steele, “Hyperimmunoglobulinemia E, (Job) Syndrome,” http://emedicine.medscape.com/article/886988-overview

B. R. Powell, N. R. M. Buist, and P. Stenzel, “An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy,” Journal of Pediatrics, vol. 100, no. 5, pp. 731–737, 1982.

A. O. Shigeoka, P. F. Chance, P. R. Fain, D. F. Barker, L. S. Book, and M. L. Rallison, “Regional localization of a novel X-linked immunodeficiency with autoimmune disease and enteropathies to the Wiskott-Aldrich locus Xp11.2,” Pediatric Research, vol. 33, article 158A, 1993.

P. J. Ferguson, S. H. Blanton, F. T. Saulsbury et al., “Manifestations and linkage analysis in X-linked autoimmuniyi-immunodefficciency syndrome,” The American Journal of Medical Genetics, vol. 90, no. 5, pp. 390–397, 2000.

C. L. Bennet, R. Yoshioka, H. Kiosawa, D. F. Barker, and P. R. Fain, “X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3,” The American Journal of Human Genetics, vol. 66, no. 2, pp. 461–468, 2000.

T. R. Torgerson and H. D. Ochs, “Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells,” Journal of Allergy and Clinical Immunology, vol. 120, no. 4, pp. 744–752, 2007.

E. D'Hennezel, M. Ben-Shoshan, H. D. Ochs et al., “FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1710–1713, 2009.

F. de Benedetti, A. Insalaco, A. Diamanti et al., “Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome,” Clinical Gastroenterology and Hepatology, vol. 4, no. 5, pp. 653–659, 2006.

Y. Hashimura, K. Nozu, H. Kanegane et al., “Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome,” Pediatric Nephrology, vol. 24, no. 6, pp. 1181–1186, 2009.

K. W. Bae, B. E. Kim, J.-H. Choi et al., “A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome,” European Journal of Pediatrics, vol. 170, no. 12, pp. 1611–1615, 2011.

E. Gambineri, L. Perroni, L. Passerini et al., “Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity,” Journal of Allergy and Clinical Immunology, vol. 122, no. 6, pp. 1105–1112, 2008.

G. Lal and J. S. Bromberg, “Epigenetic mechanisms of regulation of Foxp3 expression,” Blood, vol. 114, no. 18, pp. 3727–3735, 2009.

U. Baron, S. Floess, G. Wieczorek et al., “DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3⁺ conventional T cells,” European Journal of Immunology, vol. 37, no. 9, pp. 2378–2389, 2007.

F. Barzaghi, L. Passerini, E. Gambineri et al., “Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome,” Journal of Autoimmunity, vol. 38, no. 1, pp. 49–58, 2012.